In addition, as the conjugation with colloidal nanoparticles seems to affect the therapeutic efficacy of TZ13, we explored the anticancer activity of MNP-HC both in HER2+ TZ-sensitive and resistant breast cancer cells. The gene discussed is ERBB2; the disease is breast cancer.